(76 days)
No
The description mentions computer-assisted design (CAD) and additive manufacturing, which are standard digital design and fabrication techniques, but does not mention any AI or ML components.
Yes
The device is a dental implant support structure used to restore chewing function in patients with partially or totally edentulous jaws, which is a therapeutic purpose.
No
The device is an endosseous dental implant support structure designed to restore chewing function, not to diagnose a medical condition.
No
The device description explicitly states the device is fabricated using additive manufacturing to produce a customized, patient-specific physical structure (a dental implant support structure). It also details performance testing on physical samples.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The ATLANTIS® Conus Structure is a patient-specific dental implant support structure designed to restore chewing function in edentulous jaws. It is a physical device implanted in the mouth, not a test performed on a biological sample.
- Intended Use: The intended use clearly states its purpose is for "restoring chewing function" and "attachment to ATLANTIS® Conus abutment, Overdenture (OD)". This is a mechanical and structural function, not a diagnostic one.
- Device Description: The description details its fabrication through CAD and additive manufacturing and its different design types for supporting dental prostheses. This aligns with a medical device for structural support, not an IVD.
- Performance Studies: The performance studies focus on mechanical properties like dynamic fatigue, bond strength, and dimensional verification, which are relevant to the structural integrity and fit of a dental implant component, not the accuracy of a diagnostic test.
Therefore, the ATLANTIS® Conus Structure falls under the category of a medical device, specifically a dental prosthesis component, and not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The ATLANTIS® Conus Structure is indicated for attachment to ATLANTIS® Conus abutment, Overdenture (OD) via prefabricated SynCone 5° Taper caps (Degulor®) in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The ATLANTIS® Conus Structure is intended for conical attachment to a minimum of four (4) ATLANTIS® Conus abutments, Overdenture (OD). The ATLANTIS® Conus Structure is only intended for acrylic or composite veneering.
Product codes (comma separated list FDA assigned to the subject device)
NHA
Device Description
The proposed ATLANTIS® Conus structure is a patient-specific endosseous dental implant support structure that is indicated for attachment to dental abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The design of the proposed device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the ATLANTIS® Conus Structure is fabricated using additive manufacturing to produce a customized, patient-specific device.
The proposed ATLANTIS® Conus Structure is available in the following design types:
-
- ATLANTIS® Conus Bridge Intended for direct veneering using dental resin composites resulting in a removable friction-retained prosthesis. The bridge provides a full anatomical base for composite layering techniques.
-
- ATLANTIS® Conus Hybrid Intended as a removable friction-retained denture framework. The hybrid variant provides a surface with retention elements that can be finished with resin-based denture prosthesis.
-
- ATLANTIS® Conus Base Intended as a removable friction-retained denture framework for finishing with the resin-based denture prosthesis.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
partially or totally edentulous jaws
Indicated Patient Age Range
Not Found
Intended User / Care Setting
dental clinicians
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Performance Data
Performance testing:
- -Dynamic fatigue tests on worst case test samples of the proposed ATLANTIS® Conus Structures, based on ISO 14801 Dentistry - Implants - Dynamic fatigue test for endosseous dental implants
- -Testing in order to verify the bond strength of the SynCone® 5° Taper caps (Degulor®) and the ATLANTIS® Conus Structure when subjected to pull-off loads.
- -Dimensional verification analysis of the conical connection cavities of the proposed ATLANTIS® Conus Structures to ensure correct fit with SynCone® 5° Taper caps (Degulor®).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K130999, K151039, K160626, K161030, K172225, K131644
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white. To the right of the square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
July 18, 2018
Dentsply Sirona Karl Nittinger Director, Corporate Regulatory Affairs 221 W Philadelphia Street. Suite 60W York, Pennsylvania 17401
Re: K181189
Trade/Device Name: ATLANTIS® Conus Structure Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: May 1, 2018 Received: May 3, 2018
Dear Karl Nittinger:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Andrew I. Steen -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
K181189
Device Name ATLANTIS® Conus Structure
Indications for Use (Describe)
The ATLANTIS® Conus Structure is indicated for attachment to ATLANTIS® Conus abutment, Overdenture (OD) via prefabricated SynCone 5° Taper caps (Degulor®) in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The ATLANTIS® Conus Structure is intended for conical attachment to a minimum of four (4) ATLANTIS® Conus abutments, Overdenture (OD). The ATLANTIS® Conus Structure is only intended for acrylic or composite veneering.
Type of Use (Select one or both, as applicable) | |
---|---|
------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW .
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
EF
3
Dentsply Sirona 221 West Philadelphia Street Suite 60 York, PA 17404
Image /page/3/Picture/2 description: The image contains the logo for Dentsply Sirona. The logo consists of a stylized leaf-like shape on the left, followed by the text "Dentsply" on the top line and "Sirona" on the bottom line. The text is in a simple, sans-serif font and is aligned to the right of the leaf-like shape.
SECTION 5. 510(k) SUMMARY
for
ATLANTIS® Conus Structure
-
- Submitter Information:
Dentsply Sirona 221 West Philadelphia Street Suite 60W York, PA 17401
- Submitter Information:
Contact Person: | Karl Nittinger |
---|---|
Telephone Number: | 717-849-4424 |
Fax Number: | 717-849-4343 |
Date Prepared: 17-July-2018
-
- Device Name:
- Proprietary Name: ATLANTIS® Conus Structure .
- Classification Name: Endosseous dental implant abutment. ●
Class II
- . CFR Number: 21 CFR 872.3630
- Device Class: ●
- . Product Code: NHA (Abutment, Implant, Dental Endosseous)
-
- Predicate Device:
The predicate and reference devices that have been identified relating to the substantial equivalence of the ATLANTIS® Conus Structure are:
Predicate Device Name | 510(k) | Company Name |
---|---|---|
ATLANTIS™ Suprastructures | K163398 | Dentsply Sirona |
Reference Device Name | 510(k) | Company Name |
OsseoSpeed™ Profile EV | K130999 | Dentsply Sirona |
ATLANTIS™ Abutment for NobelActive 3.0 | K151039 | Dentsply Sirona |
ATLANTIS™ Abutment for HIOSSEN ET implant | K160626 | Dentsply Sirona |
ATLANTIS™ Abutment for CONELOG implant | K161030 | Dentsply Sirona |
ATLANTIS™ Abutment for MIS implant | K172225 | Dentsply Sirona |
ANKYLOS® SynCone® Abutment 5° | K131644 | Dentsply Sirona |
4
4. Description of Device:
The proposed ATLANTIS® Conus structure is a patient-specific endosseous dental implant support structure that is indicated for attachment to dental abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The design of the proposed device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the ATLANTIS® Conus Structure is fabricated using additive manufacturing to produce a customized, patient-specific device.
The proposed ATLANTIS® Conus Structure is available in the following design types:
-
- ATLANTIS® Conus Bridge Intended for direct veneering using dental resin composites resulting in a removable friction-retained prosthesis. The bridge provides a full anatomical base for composite layering techniques.
-
- ATLANTIS® Conus Hybrid Intended as a removable friction-retained denture framework. The hybrid variant provides a surface with retention elements that can be finished with resin-based denture prosthesis.
-
- ATLANTIS® Conus Base Intended as a removable friction-retained denture framework for finishing with the resin-based denture prosthesis.
-
- Indications for Use:
ATLANTIS® Conus Structure is indicated for attachment to ATLANTIS® Conus Abutment, Overdenture (OD) via prefabricated SynCone® 5° Taper caps (Degulor®) in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
The ATLANTIS® Conus Structure is intended for conical attachment to a minimum of four (4) ATLANTIS® Conus abutments, Overdenture (OD). The ATLANTIS® Conus Structure is only intended for acrylic or composite veneering.
- Substantial Equivalence 6.
Technological Characteristics
An overview of the similarities and differences between the proposed and predicate device is given in Table 1: Similarities and Differences between the proposed and the predicate device.
The subject ATLANTIS® Conus Structures are manufactured using the same materials (titanium alloy) and are produced using the identical additive manufacturing processes as are the primary predicate ATLANTIS™ Suprastructures (K163398) devices.
The proposed ATLANTIS® Conus Structure features the same design variants (Bridge and Hybrid) as the predicate device ATLANTIS™ Suprastructures (K163398). In addition to the Bridge and Hybrid variants, the proposed ATLANTIS® Conus Structure also features
5
the ATLANTIS® Conus Base variant which is a more basic version of the Hybrid as it does not have teeth retention elements on its surface nor the optional extra retention surface profile.
Additionally, the proposed ATLANTIS® Conus Structures which are the subject of this premarket notification feature the same options related to surface profile characteristics as do predicate ATLANTIS™ Suprastructures cleared in K163398. The optional cell retention and pin retention surface profiles of both the subject (with the exception of the subject device's "base" variant) and predicate devices are intended to enhance the surface area available for the mechanical retention of prosthetic materials that are applied to the underlying structures.
With respect to fundamental technology, the subject ATLANTIS® Conus Structures are identical to the primary predicate, the ATLANTIS™ Suprastructures (K163398), with the exception of the interface between the abutment / implant. The proposed ATLANTIS® Conus Structure is a removable structure (friction retained), while the predicate ATLANTIS™ Suprastructures (K163398) is a fixed structure (screw-retained).
While the primary predicate device (K163398) features pre-manufactured, implantspecific interface geometries to facilitate screw-retained connection to implants and abutments, the subject ATLANTIS® Conus Structures are intended for attachment to ATLANTIS® Conus abutments, Overdenture (OD) by friction retention via the currently marketed SynCone 5° Taper caps (Degulor®). The SynCone 5° Taper caps, cleared under reference device K131644, are cemented into recesses in the subject ATLANTIS® Conus Structures and facilitate the tapered friction-fit connection to the conical shape of the ATLANTIS™ Conus Abutment reference devices. The ATLANTIS™ Conus Abutment reference devices are specifically cleared for use with the SynCone 5° Taper caps for tapered friction-fit retention of removable prostheses in their clearances under K130999, K151039, K160626, and K172225. All technologies incorporated in the subject ATLANTIS® Conus Structures have been previously 510(k)-cleared; with the intended use and fundamental technologies cleared in the primary predicate device (K163398) and the tapered friction-fit method cleared in the reference devices, as listed in Section 3 of this 510(k) Summary.
Indications for Use Comparison
The difference in implant / abutment connection method between the subject ATLANTIS® Conus Structures and the primary predicate ATLANTIS™ Suprastructures (K163398) is reflected in the indications for use of the two devices. Because the connection method incorporated in the primary predicate device (K163398) is fixed (i.e., screw retention) and the connection geometries are manufactured to accommodate connection to specific implant and abutment systems, the indications for use of the primary predicate device (K163398) includes an overview of all implant and abutment systems. This is not applicable to the indications for use of the ATLANTIS® Conus Structures due to the fact that all of the ATLANTIS™ Conus Abutment reference devices, to which the subject
6
ATLANTIS® Conus Structures are friction-retained, feature the same, conical taper geometry which is compatible with the 5° internal taper of the SynCone® caps.
7. Non-Clinical Performance Data
Performance testing
For the proposed ATLANTIS® Conus Structure, non-clinical performance test data are included to support substantial equivalence:
- -Dynamic fatigue tests on worst case test samples of the proposed ATLANTIS® Conus Structures, based on ISO 14801 Dentistry - Implants - Dynamic fatigue test for endosseous dental implants
- -Testing in order to verify the bond strength of the SynCone® 5° Taper caps (Degulor®) and the ATLANTIS® Conus Structure when subjected to pull-off loads.
- -Dimensional verification analysis of the conical connection cavities of the proposed ATLANTIS® Conus Structures to ensure correct fit with SynCone® 5° Taper caps (Degulor®).
Sterilization
The recommended sterilization method and validated sterilization parameters for the subject ATLANTIS® Conus Structures are identical to the sterilization method and validated parameters recommended for the primary predicate device (K163398). Therefore, no new summary sterilization validation information has been included to support substantial equivalence.
Biocompatibility
Because the subject ATLANTIS® Conus Structures are composed of the identical titanium alloy material and are manufactured utilizing the identical additive manufacturing processes, equipment, and process controls of the primary predicate device (K163398) no new biocompatibility testing has been included to support substantial equivalence.
An analysis was conducted to assess the potential for toxicological effects resulting from the interaction of materials. The results of the analysis concluded that, under worst-case conditions, no corrosion products of toxicological concern are released and thus support the biocompatibility and the substantial equivalence of the subject ATLANTIS® Conus Structures.
Clinical Performance Data 8.
No clinical performance data were submitted in support of substantial equivalence.
9. Conclusion Regarding Substantial Equivalence
The proposed ATLANTIS® Conus Structure is intended to be used by dental clinicians in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. The proposed ATLANTIS® Conus Structure has the same intended use, is composed of the same material, incorporates the same product and manufacturing
7
technology and has similar indications for use as the predicate device ATLANTIS™ Suprastructures (K163398).
Performance testing has been conducted and is included in this premarket notification to verify that the subject device meets its predetermined performance requirements and the results support a conclusion of substantial equivalence.
8
Table 1: Similarities and Differences between the proposed and predicate devices | ||||
---|---|---|---|---|
Proposed device | ||||
ATLANTIS® Conus Structures | Predicate device | |||
ATLANTISTM Suprastructures | ||||
(K163398) | Reference Device | |||
ANKYLOS® SynCone® Abutment 5° | ||||
(K131644) | ||||
Indications for | ||||
use | ATLANTIS® Conus Structure is indicated for attachment | |||
to ATLANTIS® Conus Abutment, Overdenture (OD) via | ||||
prefabricated SynCone® 5° Taper caps (Degulor®) in the | ||||
treatment of partially or totally edentulous jaws for the | ||||
purpose of restoring chewing function. |
The ATLANTIS® Conus Structure is intended for conical
attachment to a minimum of four (4) ATLANTIS® Conus
abutments, Overdenture (OD). The ATLANTIS® Conus
Structure is only intended for acrylic or composite
veneering. | ATLANTISTM Suprastructures are indicated for attachment to dental
implants or abutments in the treatment of partially or totally
edentulous jaws for the purpose of restoring chewing function.
ATLANTISTM Suprastructures are intended for attachment to a
minimum of two (2) implants and are indicated for compatibility
with the following implant and abutment systems:
Implants:
• Biomet 3i Certain 3.25, 4/3 - Prevail 3/4/3, 4/3
• Biomet 3i Certain 4.0, 5/4 - Prevail 4/5/4, 5/4
• Biomet 3i Certain 5.0,XP4/5 - Prevail 5/6/5, 6/5
• Biomet 3i Certain 6.0, XP 5/6
• BioHorizons Internal/Tapered 3.5, 4.5, 5.7
• Camlog Screw-line Implant 3.3
• Camlog Screw-line / Root-line Implant 3.8, 4.3, 5.0, 6.0
• DENTSPLY Implants XiVE S 3.0, S 3.4, S 3.8, S 4.5, S 5.5
• DENTSPLY Implants OsseoSpeed™ TX 3.0, 3.5/4.0, 4.5/5.0
• DENTSPLY Implants OsseoSpeed™ Profile TX 4.5/5.0
• DENTSPLY Implants OsseoSpeed™ EV 3.0, 3.6, 4.2, 4.8, 5,4
• DENTSPLY Implants OsseoSpeed™ Profile EV 4.2, 4.8
• Keystone Dental PrimaConnex SD 3.3/3.5
• Keystone Dental PrimaConnex RD 4.0/4.1
• Keystone Dental PrimaConnex WD 5.0
• Keystone Dental Genesis 3.8, 4.5, 5.5/6.5
• Nobel Biocare NobelActive NP 3.5 - RP 4.3, 5.0
• Nobel Biocare NobelReplace NP 3.5 - RP 4.3 - WP 5.0 - 6.0
• Straumann Bone Level 3.3 NC - 4.1, 4.8 RC
• Straumann Standard Plus 3.5 NN
• Straumann Standard/Standard Plus 4.8 RN - 4.8 WN
• Zimmer Dental Tapered S-V 3.5/ S-V 3.3, 3.7 / S-V 4.5/ S-V 4.5
• Zimmer Dental Tapered Screw-Vent 5.7
Abutments:
• Biomet 3i Low Profile Abutment
• DENTSPLY Implants ATIS Uni Abutment EV
• DENTSPLY Implants ATIS UniAbutment 20°, ATIS UniAbutment 45°
• DENTSPLY Implants ATIS Angled Abutment EV,
ATIS Angled Abutment 20°
• DENTSPLY Implants ANKYLOS Balance Base Narrow D4.2, Balance
Base D5.5
• DENTSPLY Implants XIVE MP 3.4, MP 3.8, MP 4.5, MP 5.5
• DENTSPLY Implants XiVE TG 3.4, TG 3.8, TG 4.5
• Nobel Biocare Multi-Unit Abutment RP
• Straumann Bone Level Multi-Base Angled Abutment
• Straumann Bone Level Multi-Base Abutment D3.5, D4.5
• Straumann RN Abutment Level, WN Abutment Level
• Straumann Screw-Retained Abutment 3.5, 4.6
• Zimmer Dental Tapered Abutment | SynCone® Abutments on osseointegrated
implants:
Anchorage of dentures retained by taper
friction and supported by ANKYLOS®
implants.
SynCone® Abutments for immediate
loading:
Immediate loading of an implant supported
prosthesis in an edentulous mandible
supported by 4 ANKYLOS® implants of at
least 11 mm in length and placed
interforaminally. | |
| Table 1 (continued): Similarities and Differences between the proposed and predicate devices | | | | |
| | Proposed device
ATLANTIS® Conus Structures | Predicate device
ATLANTISTM Suprastructures
(K163398) | Reference Device
ANKYLOS® SynCone®
Abutment 5°
(K131644) | Summary of Differences |
| Design | | | | |
| Restoration | Multi-unit | Multi-unit | Multi-unit | No differences. |
| Design Type | Hybrid, Bridge, Base | Hybrid, Bridge | Individual endosseous dental implant
abutments. | The proposed device is offered in a "base" variant,
not offered in the predicate device. The "base"
variant is identical to the hybrid variant with
exception that it does not feature retention pins and
is not offered with the mechanical retention surface
profile. The reference devices (K131644) are
standardized endosseous dental implant abutments
which are included in relation to their use with the
SynCone® 5° taper caps to facilitate friction
retention of prosthetic restorations. |
| Prosthesis
Attachment | Friction-retained via 5° SynCone® caps. | Screw-retained | Friction-retained via 5°
SynCone® caps. | Predicate device (K163398) incorporates implant
system-specific interface geometry to facilitate
screw retention with implants. Proposed device does
not interface directly with implants, instead, as does
the reference device (K131644), relies on taper
friction fit with currently marketed Conus abutments
via currently marketed SynCone® caps. |
| Design
Technology | CAD/CAM (Additive Manufacturing) | CAD/CAM (Additive
Manufacturing) | Standardized abutment design. | No differences between proposed and
predicate devices. The reference devices
(K131644) are standardized endosseous dental
implant abutments which are included in relation to
their use with the SynCone® 5° taper caps to
facilitate friction retention of prosthetic restorations. |
| Mechanical
retention
surface feature
options | No retention (Base, Bridge, and Hybrid)
Cell retention (Hybrid)
Pin retention (Bridge and Hybrid) | No retention (Bridge and Hybrid)
Cell retention (Hybrid)
Pin retention (Bridge and Hybrid) | Not applicable. | No differences between the proposed device
and predicate device. The reference devices
(K131644) are standardized endosseous dental
implant abutments which are included in relation to
their use with the SynCone® 5° taper caps to
facilitate friction retention of prosthetic restorations. |
| Material | | | | |
| Material | Titanium alloy | Titanium alloy, CoCr | Titanium alloy | While the predicate device (K163398) was cleared
in both Ti alloy and CoCr materials, the proposed
device is available in Ti alloy material only. |
9
10
Table 2: Summary comparison of ATLANTIS® Conus Structures and Reference Devices | ||||||
---|---|---|---|---|---|---|
Proposed Device | Reference Devices | |||||
Dentsply Sirona | ||||||
ATLANTIS® Conus | ||||||
Structure | Dentsply Sirona | |||||
OsseoSpeed™ Profile | ||||||
EV | ||||||
(K130999) | Dentsply Sirona | |||||
ATLANTIS™ Abutment | ||||||
for NobelActive 3.0 | ||||||
(K151039) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for | ||||||
HIOSSEN ET implant | ||||||
(K160626) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for | ||||||
CONELOG implant | ||||||
(K161030) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for MIS | ||||||
Implant | ||||||
(K172225) | Summary of Differences | |||||
Design | ||||||
Prosthesis Attachment | ||||||
Friction fit | Friction fit | |||||
Screw-retained | ||||||
Cement-retained | Friction fit | |||||
Screw-retained | ||||||
Cement-retained | Friction fit | |||||
Screw-retained | ||||||
Cement-retained | Friction fit | |||||
Screw-retained | ||||||
Cement-retained | Friction fit | |||||
Screw-retained | ||||||
Cement-retained | Fundamentally, no difference. | |||||
Both the proposed ATLANTIS® | ||||||
Conus Structures and the reference | ||||||
devices incorporate friction fit | ||||||
attachment and, to facilitate this | ||||||
friction fit attachment, the | ||||||
proposed and reference devices | ||||||
utilize the currently marketed | ||||||
SynCone® tapered caps. | ||||||
Restoration | ||||||
Multi-unit | Multi-unit | |||||
Single unit | Multi-unit. | |||||
Single unit. | Multi-unit. | |||||
Single unit. | Multi-unit. | |||||
Single unit. | Multi-unit. | |||||
Single unit. | Fundamentally, no difference. The | |||||
reference devices may be used for | ||||||
single-tooth prosthetic restoration, | ||||||
but also may be used in support of | ||||||
multi-unit prostheses via their | ||||||
ATLANTIS® Conus Abutment | ||||||
variants using the SynCone® caps. | ||||||
Abutment Platform Diameter (mm) | ||||||
N/A | 3.0, 4.3, 5.0 | 3.0 | 3.5, 4.0, 4.5, 5.0, 6.0, 7.0 | 3.3, 3.8, 4.3, 5.0 | 3.3, 3.75, 4.2, 5.0, 6.0 | This design element is not |
applicable to the proposed | ||||||
ATLANTIS® Conus Structures. | ||||||
Abutment angulation | ||||||
N/A | 0° - 30° | 0° - 30° | 0° - 30° | 0° - 30° | 0° - 30° | This design element is not |
applicable to the proposed | ||||||
ATLANTIS® Conus Structures. | ||||||
Implant Connection Type | ||||||
N/A | Internal | Internal | Internal | Internal | Internal | This design element is not |
applicable to the proposed | ||||||
ATLANTIS® Conus Structures. | ||||||
Table 2 (continued): Summary comparison of ATLANTIS® Conus Structures and Reference Devices | ||||||
Proposed Device | Reference Devices | Summary of Differences | ||||
Dentsply Sirona | ||||||
ATLANTIS® Conus | ||||||
Structure | Dentsply Sirona | |||||
OsseoSpeed™ Profile | ||||||
EV | ||||||
(K130999) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for | ||||||
NobelActive 3.0 | ||||||
(K151039) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for | ||||||
HIOSSEN ET implant | ||||||
(K160626) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for | ||||||
CONELOG implant | ||||||
(K161030) | Dentsply Sirona | |||||
ATLANTIS™ Abutment for MIS | ||||||
implant | ||||||
(K172225) | Summary of Differences | |||||
Material | ||||||
Titanium alloy | Titanium alloy, Yttria | |||||
Stabilized Zirconia | Titanium alloy | Titanium alloy, Yttria | ||||
Stabilized Zirconia | Titanium alloy | Titanium alloy, Zirconia | No difference. The proposed | |||
ATLANTIS® Conus Structure is | ||||||
available only in titanium alloy | ||||||
material. The reference devices are | ||||||
available in the same titanium alloy | ||||||
material (although they are milled | ||||||
rather than fabricated by additive | ||||||
manufacturing), but are also available | ||||||
in zirconia ceramic material in some | ||||||
cases as noted. |
11